UTMB SCVD ~ The Future

Home Vaccine Related Publications
	2001 2002 2003 2004

Arany I, Grattendick KG, Tyring SK. Interleukin-10 induces transcription of the early promoter of human papillomavirus type 16 (HPV16) through the 5'-segment of the upstream regulatory region (URR). Antiviral Res 55 (2): 331-9, 2002.

Arany I, Whitehead WE, Grattendick KJ, Ember IA, Tyring SK. Suppression of growth by all-trans retinoic acid requires prolonged induction of interferon regulatory factor 1 in cervical squamous carcinoma (SiHa) cells. Clin Diagn Lab Immunol 9 (5): 1102-6, 2002.

Baer RD, Weller, S.C. Designing a questionnaire for cross-cultural research. In: Angrosino MV, ed. Doing Cultural Anthropology: Prospect Heights: Waveland Press, pp. 115-122, 2002.

Bakaletz LO, Barenkamp SJ, Eskola J, Green B, Gu XX, Harada T, Heikkinen T, Karma P, Klein JO, Kurono Y, Mogi G, Murphy TF, Ogra PL, Patel JA, Suzuki M, Yamanaka N. Recent advances in otitis media. 7. Vaccine. Ann Otol Rhinol Laryngol Suppl 188: 82-94, 2002.

Banerjee S, Narayanan K, Mizutani T, Makino S. Murine coronavirus replication-induced p38 mitogen-activated protein kinase activation promotes interleukin-6 production and virus replication in cultured cells. J Virol 76 (12): 5937-48, 2002.

Bard JS. Unjust Rules for Insanity. The New York Times 2002 March 13, 2002.

Bard JS. Failed Insanity Defense Exposes Flaws in Texas Law. Houston Chronicle 2002 March 14, 2002.

Bard JS. Texas' Unjust Insanity Rules. Honolulu Advertiser 2002 March 14, 2002.

Bard JS. Why The Insanity Defense Is Flawed. Lawyers Weekly USA 2002 April 15, 2002.

Bard JS. How Can We Learn From Our Mistakes: The Legacy of the Anthrax Vaccine. Health Law News 2002 April 2002;p. 8.

Bard JS. Pleading Insanity: What the Andrea Yates Case Reveals About American Views of Mental Illness. Wellesley 86 (4): 16-17, 2002.

Baron S, Salazar, A., Pestka, S., & Poast, J. Smallpox: Prevention by IFN and an IFN inducer. Journal of Interferon and Cytokine Research 22 (1): 86, 2002.

Barrera C, Espejo R, Reyes VE. Differential glycosylation of MHC class II molecules on gastric epithelial cells: implications in local immune responses. Hum Immunol 63 (5): 384-93, 2002.

Barrera R, Ferro C, Navarro JC, Freier J, Liria J, Salas R, Ahumada M, Vasquez C, Gonzalez M, Kang W, Boshell J, Weaver SC. Contrasting sylvatic foci of Venezuelan equine encephalitis virus in northern South America. Am J Trop Med Hyg 67 (3): 324-34, 2002.

Barrera C, Chan, T., Crowe, S.E., Ernst, P.B., Reyes, V.E. Ii-CS on gastric epithelial cell interacts with CD44 on T cells and induces their proliferation. Annals NYAS, 2002.

Barrera R, Torres1, N., Freier, J.E., Navarro, J.C., García, C.Z., Salas, R., Vasquez, C., WEAVER, S.C. Characterization of enzootic foci of Venezuelan equine encephalitis virus in western Venezuela. Vector Borne Zoon Dis 1 (3): 219-230, 2002.

Barrett A. Arboviruses. Encyclopedia of Molecular Medicine, pp. 245-247, 2002.

Barrett A, & Weaver, SC. Arboviruses: alphaviruses flaviviruses and bunyaviruses. Medical Microbiology. 16 ed, pp. 482-494, 2002.

Baxt B, Neff, S., Rieder, E., Mason, P.W. Foot-and-mouth disease virus - receptor interactions: Role in pathogenesis and tissue culture adaptation. In: Semler BL, Wimmer, E., ed. Molecular Biology of Picornaviruses. Washington, DC: ASM Press, pp. 115-123, 2002.

Beasley DW, Li L, Suderman MT, Barrett AD. Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype. Virology 296 (1): 17-23, 2002.

Beasley DW, Barrett AD. Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein. J Virol 76 (24): 13097-100, 2002.

Bennett KE, Olson KE, Munoz Mde L, Fernandez-Salas I, Farfan-Ale JA, Higgs S, Black WCt, Beaty BJ. Variation in vector competence for dengue 2 virus among 24 collections of Aedes aegypti from Mexico and the United States. Am J Trop Med Hyg 67 (1): 85-92, 2002.

Berman S, Casselbrant ML, Chonmaitree T, Giebink GS, Grote JJ, Ingvarsson LB, Linder T, Lous J, Maw AR, Paradise JL, Sando I, Stool SE, Takasaka T. Recent advances in otitis media. 9. Treatment, complications, and sequelae. Ann Otol Rhinol Laryngol Suppl 188: 102-24, 2002.

Berman S, Casselbrant ML, Chonmaitree T, Giebink GS, Grote JJ, Ingvarsson LB, Linder T, Lous J, Maw AR, Paradise JL, Sando I, Stool SE, Takasaka T. Recent advances in otitis media. 9. Treatment, complications, and sequelae. Ann Otol Rhinol Laryngol Suppl 188: 102-24, 2002.

Boldogh I, Patel, J.A., Tyring S.K., Chonmaitree, T. Cytomegalovirus. In: Tyring SK, ed. Mucocutaneous manifestations of viral disease. New York, NY: Marcel Decker, Inc., 2002.

Borio L, Inglesby T, Peters CJ, Schmaljohn AL, Hughes JM, Jahrling PB, Ksiazek T, Johnson KM, Meyerhoff A, O'Toole T, Ascher MS, Bartlett J, Breman JG, Eitzen EM, Jr., Hamburg M, Hauer J, Henderson DA, Johnson RT, Kwik G, Layton M, Lillibridge S, Nabel GJ, Osterholm MT, Perl TM, Russell P, Tonat K. Hemorrhagic fever viruses as biological weapons: medical and public health management. Jama 287 (18): 2391-405, 2002.

Bourne N, Bravo FJ, Francotte M, Bernstein DI, Myers MG, Slaoui M, Stanberry LR. Herpes Simplex Virus (HSV) Type 2 Glycoprotein D Subunit Vaccines and Protection against Genital HSV-1 or HSV-2 Disease in Guinea Pigs. J Infect Dis 187 (4): 542-9, 2003.

Bourne N, Pyles RB, Bernstein DI, Stanberry LR. Modification of primary and recurrent genital herpes in guinea pigs by passive immunization. J Gen Virol 83 (Pt 11): 2797-801, 2002.

Brady RC, Stanberry, L.R. Perinatal Viral Infections. In: Jenson HB, Baltimore, R.S., ed. Pediatric Infectious Diseases: Principles and Practice. 2nd ed. Philadelphia: W.B. Saunders Company, pp. 1135-1147, 2002.

Brault AC, Powers AM, Holmes EC, Woelk CH, Weaver SC. Positively charged amino acid substitutions in the e2 envelope glycoprotein are associated with the emergence of venezuelan equine encephalitis virus. J Virol 76 (4): 1718-30, 2002.

Brault AC, Powers AM, Weaver SC. Vector infection determinants of Venezuelan equine encephalitis virus reside within the E2 envelope glycoprotein. J Virol 76 (12): 6387-92, 2002.

Brentjens MH, Yeung-Yue KA, Lee PC, Tyring SK. Human papillomavirus: a review. Dermatol Clin 20 (2): 315-31, 2002.

Brewer D, Johnson, J.C., Weller, S.C. Introduction to endogamy, scaling, and social cognition in social networks: Special issue in honor of A. Kimball Romney. Social Networks 24 (3): 183-184, 2002.

Brown TJ, McCrary M, Tyring SK. Antiviral agents: Non-antiretroviral [correction of Nonantiviral] drugs. J Am Acad Dermatol 47 (4): 581-99, 2002.

Brown T, Yen-Moore, A., Tyring, S.K. Herpes virus 8. In: Tyring SK, ed. Mucocutaneous Manifestations of Viral Diseases. New York: Marcel Dekker, Inc., pp. 219-234, 2002.

Carrasco D, vander Straten M, Tyring SK. Treatment of anogenital warts with imiquimod 5% cream followed by surgical excision of residual lesions. J Am Acad Dermatol 47 (4 Suppl): S212-6, 2002.

Carrasco DA, Vander Straten M, Tyring SK. A review of antibiotics in dermatology. J Cutan Med Surg 6 (2): 128-50, 2002.

Casola A, Garofalo RP, Crawford SE, Estes MK, Mercurio F, Crowe SE, Brasier AR. Interleukin-8 gene regulation in intestinal epithelial cells infected with rotavirus: role of viral-induced IkappaB kinase activation. Virology 298 (1): 8-19, 2002.

Casola A, Henderson A, Liu T, Garofalo RP, Brasier AR. Regulation of RANTES promoter activation in alveolar epithelial cells after cytokine stimulation. Am J Physiol Lung Cell Mol Physiol 283 (6): L1280-90, 2002.

Chapman LE, Ellis BA, Koster FT, Sotir M, Ksiazek TG, Mertz GJ, Rollin PE, Baum KF, Pavia AT, Christenson JC, Rubin PJ, Jolson HM, Behrman RE, Khan AS, Bell LJ, Simpson GL, Hawk J, Holman RC, Peters CJ. Discriminators between hantavirus-infected and -uninfected persons enrolled in a trial of intravenous ribavirin for presumptive hantavirus pulmonary syndrome. Clin Infect Dis 34 (3): 293-304, 2002.

Chen CJ, Makino S. Murine coronavirus-induced apoptosis in 17Cl-1 cells involves a mitochondria-mediated pathway and its downstream caspase-8 activation and bid cleavage. Virology 302 (2): 321-32, 2002.

Chen JJ, Huang JC, Shirtliff M, Briscoe E, Ali S, Cesani F, Paar D, Cloyd MW. CD4 lymphocytes in the blood of HIV(+) individuals migrate rapidly to lymph nodes and bone marrow: support for homing theory of CD4 cell depletion. J Leukoc Biol 72 (2): 271-8, 2002.

Chen J, Wang L, Chen JJ, Sahu GK, Tyring S, Ramsey K, Indrikovs AJ, Petersen JR, Paar D, Cloyd MW. Detection of antibodies to human immunodeficiency virus (HIV) that recognize conformational epitopes of glycoproteins 160 and 41 often allows for early diagnosis of HIV infection. J Infect Dis 186 (3): 321-31, 2002.

Cotton S, Connelly BL, Cohen SS, Siegel RM, Stanberry LR, Rosenthal SL. Screening for neonatal herpes: physicians' descriptions of discussions with parents. Herpes 9 (3): 60-3, 2002.

DeMaria TF, Bakaletz LO, Chonmaitree T, Heikkinen T, Hurst DS, Kawauchi H, Kurono Y, Patel JA, Sih TM, Stenfors LE, Suzuki M. Recent advances in otitis media. 6. Microbiology and immunology. Ann Otol Rhinol Laryngol Suppl 188: 62-81, 2002.

DeMaria TF, Bakaletz LO, Chonmaitree T, Heikkinen T, Hurst DS, Kawauchi H, Kurono Y, Patel JA, Sih TM, Stenfors LE, Suzuki M. Recent advances in otitis media. 6. Microbiology and immunology. Ann Otol Rhinol Laryngol Suppl 188: 62-81, 2002.

Dianzani F, Antonelli G, Riva E, Turriziani O, Antonelli L, Tyring S, Carrasco DA, Lee H, Nguyen D, Pan J, Poast J, Cloyd M, Baron S. Is human immunodeficiency virus RNA load composed of neutralized immune complexes? J Infect Dis 185 (8): 1051-4, 2002.

Dong A, Malecki JM, Lee L, Carpenter JF, Lee JC. Ligand-induced conformational and structural dynamics changes in Escherichia coli cyclic AMP receptor protein. Biochemistry 41 (21): 6660-7, 2002.

Drebot MA, Henchal E, Hjelle B, LeDuc JW, Repik PM, Roehrig JT, Schmaljohn CS, Shope RE, Tesh RB, Weaver SC, Calisher CH. Improved clarity of meaning from the use of both formal species names and common (vernacular) virus names in virological literature. Arch Virol 147 (12): 2465-72, 2002.

Eickhoff TC, Myers M. Workshop summary. Aluminum in vaccines. Vaccine 20 Suppl 3: S1-4, 2002.

Enria D, Peters, C.J. Other Viruses and Emerging Viruses of Concern. In: Boucher CAB, Gallasso, G.A., ed. Practical Guidelines in Antiviral Therapy. Amsterdam, pp. 279-301, 2002.

Enria D, Peters, C.J. Other Viruses and Emerging Viruses of Concern. In: Boucher CAB, Galasso, G.A., ed. Practical Guidelines in Antiviral Therapy. Amsterdam, pp. 279-301, 2002.

Ferguson MR, Rojo DR, von Lindern JJ, O'Brien WA. HIV-1 replication cycle. Clin Lab Med 22 (3): 611-35, 2002.

Ferguson MR, Rojo, D., von Lindern, J.J., O'Brien, W.A. HIV-1 replication cycle. In: Pomerantz R, ed. Clinical HIV Virology: W.B. Saunders, 2002.

Flaitz CM, Nichols CM, Walling DM, Hicks MJ. Plasmablastic lymphoma: an HIV-associated entity with primary oral manifestations. Oral Oncol 38 (1): 96-102, 2002.

Frampton MW, Boscia J, Roberts NJ, Jr., Azadniv M, Torres A, Cox C, Morrow PE, Nichols J, Chalupa D, Frasier LM, Gibb FR, Speers DM, Tsai Y, Utell MJ. Nitrogen dioxide exposure: effects on airway and blood cells. Am J Physiol Lung Cell Mol Physiol 282 (1): L155-65, 2002.

Frolova EI, Fayzulin RZ, Cook SH, Griffin DE, Rice CM, Frolov I. Roles of nonstructural protein nsP2 and Alpha/Beta interferons in determining the outcome of Sindbis virus infection. J Virol 76 (22): 11254-64, 2002.

Fuller CL, Braciale VL, Samelson LE. All roads lead to actin: the intimate relationship between TCR signaling and the cytoskeleton. Immunol Rev 191: 220-36, 2003.

Futamura N, Mukai Y, Sakaguchi M, Yasueda H, Inouye S, Midoro-Horiuti T, Goldblum RM, Shinohara K. Isolation and characterization of cDNAs that encode homologs of a pathogenesis-related protein allergen from Cryptomeria japonica. Biosci Biotechnol Biochem 66 (11): 2495-500, 2002.

Garg N, Tarleton RL. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection. Infect Immun 70 (10): 5547-55, 2002.

Garman ME, Tyring SK. The cutaneous manifestations of HIV infection. Dermatol Clin 20 (2): 193-208, 2002.

Gessell-Lee D, Popov, V.L., Boldogh, I., Olano J., Peterson, J.W. The role of COX-1 and COX-2 in cholera. GUT, 2002.

Grubman MJ, Mason PW. Prospects, including time-frames, for improved foot and mouth disease vaccines. Rev Sci Tech 21 (3): 589-600, 2002.

Haeberle HA, Takizawa R, Casola A, Brasier AR, Dieterich HJ, Van Rooijen N, Gatalica Z, Garofalo RP. Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways. J Infect Dis 186 (9): 1199-206, 2002.

Haeberle HA, Nesti F, Dieterich HJ, Gatalica Z, Garofalo RP. Perflubron reduces lung inflammation in respiratory syncytial virus infection by inhibiting chemokine expression and nuclear factor-kappa B activation. Am J Respir Crit Care Med 165 (10): 1433-8, 2002.

Hasan RJ, Pawelczyk E, Urvil PT, Venkatarajan MS, Goluszko P, Kur J, Selvarangan R, Nowicki S, Braun WA, Nowicki BJ. Structure-function analysis of decay-accelerating factor: identification of residues important for binding of the Escherichia coli Dr adhesin and complement regulation. Infect Immun 70 (8): 4485-93, 2002.

Hengge UR, Ruzicka T, Tyring SK, Stuschke M, Roggendorf M, Schwartz RA, Seeber S. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: pathogenesis, Castleman's disease, and pleural effusion lymphoma. Lancet Infect Dis 2 (6): 344-52, 2002.

Hengge UR, Ruzicka T, Tyring SK, Stuschke M, Roggendorf M, Schwartz RA, Seeber S. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect Dis 2 (5): 281-92, 2002.

Higgs S, Beaty, B.J. Natural cycles of vector-borne pathogens. In: Marquardt WC, Kondratieff, B., Freier, J., Hagedorn, H.H., Black, W. III., James, A.A., Hemingway, J. Higgs, S., ed. The Biology of Disease Vectors: Academic Press, 2002.

Higgs S. The containment of arthropod vectors. In: Marquardt WC, Kondratieff, B., Freier, J., Hagedorn, H.H., Black, W. III., James, A.A., Hemingway, J., Higgs, S., ed. The Biology of Disease Vectors: Academic Press, 2002.

Higgs S. Care, maintenance, and experimental infection of mosquitoes. In: Marquardt WC, Kondratieff, B., Freier, J., Hagedorn, H.H., Black, W. III., James, A.A., Hemingway, J., Higgs, S., ed. The Biology of Disease Vectors: Academic Press, 2002.

Higgs S, Benedict, M.Q., Tabachnick, W.J. Arthropod Containment guidelines. In: Richmond JY, ed. Anthology of Biosafety. V., 2002.

Holbrook MR, & Barrett, ADT. Molecular epidemiology of Japanese encephalitis virus. Current Topics in Microbiology and Immunology. Vol. 267, pp. 75-90, 2002.

Ikeda M, Yi M, Li K, Lemon SM. Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells. J Virol 76 (6): 2997-3006, 2002.

Ikediobi NI, Tyring SK. Cutaneous manifestations of Epstein-Barr virus infection. Dermatol Clin 20 (2): 283-9, 2002.

Ismail N, Olano JP, Feng HM, Walker DH. Current status of immune mechanisms of killing of intracellular microorganisms. FEMS Microbiol Lett 207 (2): 111-20, 2002.

Ivanciuc O, Schein CH, Braun W. Data mining of sequences and 3D structures of allergenic proteins. Bioinformatics 18 (10): 1358-64, 2002.

Ivanciuc O, Schein CH, Braun W. SDAP: database and computational tools for allergenic proteins. Nucleic Acids Res 31 (1): 359-62, 2003.

Jartti T, van den Hoogen B, Garofalo RP, Osterhaus AD, Ruuskanen O. Metapneumovirus and acute wheezing in children. Lancet 360 (9343): 1393-4, 2002.

Ji J, Sun J, Qi H, Soong L. Analysis of T helper cell responses during infection with Leishmania amazonensis. Am J Trop Med Hyg 66 (4): 338-45, 2002.

Johnson JR, Stell AL, O'Bryan TT, Kuskowski M, Nowicki B, Johnson C, Maslow JN, Kaul A, Kavle J, Prats G. Global molecular epidemiology of the O15:K52:H1 extraintestinal pathogenic Escherichia coli clonal group: evidence of distribution beyond Europe. J Clin Microbiol 40 (6): 1913-23, 2002.

Johnson JC, Weller, S.C., Brewer, D. Introduction. Systematic Data Collection and Analysis, Special Issue of Field Methods 14 (1): 1-5, 2002.

Jones AM, Warken K, Tyring SK. The cutaneous manifestations of viral hepatitis. Dermatol Clin 20 (2): 233-47, vi, 2002.

Kahn JA, Rosenthal SL, Succop PA, Ho GY, Burk RD. Mediators of the association between age of first sexual intercourse and subsequent human papillomavirus infection. Pediatrics 109 (1): E5, 2002.

Kahn JA, Rosenthal SL, Succop PA, Ho GY, Burk RD. The interval between menarche and age of first sexual intercourse as a risk factor for subsequent HPV infection in adolescent and young adult women. J Pediatr 141 (5): 718-23, 2002.

Khoshnevis M, Tyring SK. Cytomegalovirus infections. Dermatol Clin 20 (2): 291-9, vii, 2002.

King DJ, Bassett SE, Li X, Fennewald SA, Herzog NK, Luxon BA, Shope R, Gorenstein DG. Combinatorial selection and binding of phosphorothioate aptamers targeting human NF-kappa B RelA(p65) and p50. Biochemistry 41 (30): 9696-706, 2002.

Kochel TJ, Watts DM, Halstead SB, Hayes CG, Espinoza A, Felices V, Caceda R, Bautista CT, Montoya Y, Douglas S, Russell KL. Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever. Lancet 360 (9329): 310-2, 2002.

Kunkel M, Watowich SJ. Conformational changes accompanying self-assembly of the hepatitis C virus core protein. Virology 294 (2): 239-45, 2002.

Kuwahara RT, Skinner RB, Jr., Tyring SK. Direct medical cost for surgical and medical treatment of condylomata acuminata. Arch Dermatol 138 (4): 533; author reply 533-4, 2002.

Langer RC, Li F, Vinetz JM. Identification of novel Plasmodium gallinaceum zygote- and ookinete-expressed proteins as targets for blocking malaria transmission. Infect Immun 70 (1): 102-6, 2002.

Langer RC, Li F, Popov V, Kurosky A, Vinetz JM. Monoclonal antibody against the Plasmodium falciparum chitinase, PfCHT1, recognizes a malaria transmission-blocking epitope in Plasmodium gallinaceum ookinetes unrelated to the chitinase PgCHT1. Infect Immun 70 (3): 1581-90, 2002.

Le Pogam S, Shih C. Influence of a putative intermolecular interaction between core and the pre-S1 domain of the large envelope protein on hepatitis B virus secretion. J Virol 76 (13): 6510-7, 2002.

Lemon SM, Martin, A. Hepatitis A. In: Schiff S, Maddrey, W., Sorrell, M., ed. Schiff's Diseases of the Liver. Vol. 9. New York: Lippincott Williams & Wilkins, 2002.

Lerat H, Honda M, Beard MR, Loesch K, Sun J, Yang Y, Okuda M, Gosert R, Xiao SY, Weinman SA, Lemon SM. Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology 122 (2): 352-65, 2002.

Li J, Cheng X, Lee JC. Structure and dynamics of the modular halves of Escherichia coli cyclic AMP receptor protein. Biochemistry 41 (50): 14771-8, 2002.

Li K, Prow T, Lemon SM, Beard MR. Cellular response to conditional expression of hepatitis C virus core protein in Huh7 cultured human hepatoma cells. Hepatology 35 (5): 1237-46, 2002.

Lin SH, Kovac L, Chin AJ, Chin CC, Lee JC. Ability of E. coli cyclic AMP receptor protein to differentiate cyclic nucelotides: effects of single site mutations. Biochemistry 41 (9): 2946-55, 2002.

Lin SH, Lee JC. Communications between the high-affinity cyclic nucleotide binding sites in E. coli cyclic AMP receptor protein: effect of single site mutations. Biochemistry 41 (39): 11857-67, 2002.

Lin SH, Lee JC. Linkage of multiequilibria in DNA recognition by the D53H Escherichia coli cAMP receptor protein. Biochemistry 41 (50): 14935-43, 2002.

Long SW, Zhang XF, Qi H, Standaert S, Walker DH, Yu XJ. Antigenic variation of Ehrlichia chaffeensis resulting from differential expression of the 28-kilodalton protein gene family. Infect Immun 70 (4): 1824-31, 2002.

Mackenzie J, Deubel, V., Barrett, ADT. Japanese encephalitis and West Nile Viruses in Current Topics in Microbiology and Immunology, p. pp 416, 2002.

Mackenzie JS, Barrett, ADT., & Deubel, V. The Japanese encephalitis serological group of flaviviruses: a brief introduction to the group. Current Topics in Microbiology and Immunology. Vol. 267, pp. 1-10, 2002.

Martinelli PT, Tyring SK. Human herpesvirus 8. Dermatol Clin 20 (2): 307-14, vii-viii, 2002.

Mason PW, Bezborodova SV, Henry TM. Identification and characterization of a cis-acting replication element (cre) adjacent to the internal ribosome entry site of foot-and-mouth disease virus. J Virol 76 (19): 9686-94, 2002.

McBride JW, Ndip LM, Popov VL, Walker DH. Identification and functional analysis of an immunoreactive DsbA-like thio-disulfide oxidoreductase of Ehrlichia spp. Infect Immun 70 (5): 2700-3, 2002.

McCrary M, Tyring, S.K. Varicella zoster virus. In: Tyring SK, ed. Mucocutaneous Manifestations of Viral Diseases. New York: Marcel Dekker, Inc., pp. 119-144, 2002.

Memar O, Arany, I., Tyring, S.K. Cutaneous resistance to viral infections. In: Tyring SK, ed. Mucocutaneous Manifestations of Viral Diseases. New York: Marcel Dekker, Inc., pp. 25-38, 2002.

Milligan GN, Dudley KL, Bourne N, Reece A, Stanberry LR. Entry of inflammatory cells into the mouse vagina following application of candidate microbicides: comparison of detergent-based and sulfated polymer-based agents. Sex Transm Dis 29 (10): 597-605, 2002.

Moraes MP, Mayr GA, Mason PW, Grubman MJ. Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24. Vaccine 20 (11-12): 1631-9, 2002.

Morrill JC, Peters, C.J. Pathogenicity and neurovirulence studies of a mutagen-attenuated Rift Valley fever vaccine in Rhesus monkeys. Vaccine, 2002.

Murtazina D, Puchkaev AV, Schein CH, Oezguen N, Braun W, Nanavati A, Pikuleva IA. Membrane-protein interactions contribute to efficient 27-hydroxylation of cholesterol by mitochondrial cytochrome P450 27A1. J Biol Chem 277 (40): 37582-9, 2002.

Nagata N, Jiang, Z., Bakaletz, L., Patel, J.A. Attachment-mediated cytokine potentiation by nontypable Haemophilus influenzae in respiratory syncytial virus-exposed epithelial cells. In: Lim CJ, Bluestone, C.D., ed. Recent Advances in Otitis Media- Proceedings of the Seventh International Symposium (2000) Electronic book publication. Hamilton, Canada: BC Decker Inc,, pp. 598-600, 2002.

Nannini EC, Han X, O'Brien WA, Arduino RC. Genotypic HIV-1 drug resistance testing in antiretroviral-naive subjects in Houston, Texas. J Acquir Immune Defic Syndr 29 (3): 317-9, 2002.

Neet KE, Lee JC. Biophysical characterization of proteins in the post-genomic era of proteomics. Mol Cell Proteomics 1 (6): 415-20, 2002.

Nowicki B. Urinary Tract Infection in Pregnant Women: Old Dogmas and Current Concepts Regarding Pathogenesis. Curr Infect Dis Rep 4 (6): 529-535, 2002.

Oezguen N, Adamian L, Xu Y, Rajarathnam K, Braun W. Automated assignment and 3D structure calculations using combinations of 2D homonuclear and 3D heteronuclear NOESY spectra. J Biomol NMR 22 (3): 249-63, 2002.

Okuda M, Li K, Beard MR, Showalter LA, Scholle F, Lemon SM, Weinman SA. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 122 (2): 366-75, 2002.

Olano JP, Walker DH. Human ehrlichioses. Med Clin North Am 86 (2): 375-92, 2002.

Olano JP, WALKER, D.H. Human ehrlichioses: Diagnostic challenges and therapeutic recommendations. Infect Med 19: 318-325, 2002.

Oliveira RP, Galvao MA, Mafra CL, Chamone CB, Calic SB, Silva SU, Walker DH. Rickettsia felis in Ctenocephalides spp. fleas, Brazil. Emerg Infect Dis 8 (3): 317-9, 2002.

Pachter LM, Weller SC, Baer RD, de Alba Garcia JE, Trotter RT, 2nd, Glazer M, Klein R. Variation in asthma beliefs and practices among mainland Puerto Ricans, Mexican-Americans, Mexicans, and Guatemalans. J Asthma 39 (2): 119-34, 2002.

Patera A, Ali MA, Tyring S, Warren T, Hohman P, Yu E, Cohen JI. Polymorphisms in the genes for herpesvirus entry. J Infect Dis 186 (3): 444-5, 2002.

Pazdrak K, Olszewska-Pazdrak B, Liu T, Takizawa R, Brasier AR, Garofalo RP, Casola A. MAPK activation is involved in posttranscriptional regulation of RSV-induced RANTES gene expression. Am J Physiol Lung Cell Mol Physiol 283 (2): L364-72, 2002.

Perna AG, Tyring SK. A review of the dermatologic manifestations of poxvirus infections. Dermatol Clin 20 (2): 343-6, 2002.

Peter G, Myers MG. Intussusception, rotavirus, and oral vaccines: summary of a workshop. Pediatrics 110 (6): e67, 2002.

Peters CJ, Hartley DM. Anthrax inhalation and lethal human infection. Lancet 359 (9307): 710-1, 2002.

Peters CJ, Khan AS. Hantavirus pulmonary syndrome: the new American hemorrhagic fever. Clin Infect Dis 34 (9): 1224-31, 2002.

Peters CJ, Zaki SR. Role of the endothelium in viral hemorrhagic fevers. Crit Care Med 30 (5 Suppl): S268-73, 2002.

Peters CJ. Human infection with arenaviruses in the Americas. Curr Top Microbiol Immunol 262: 65-74, 2002.

Peters CJ. Many viruses are potential agents of bioterrorism. Those developing countermeasures need to focus on lethal viruses that are stable, can be grown to high titers, and are deliverable as aerosols. ASM News 68: 168-173, 2002.

Peters CJ. Hurrying toward disaster? Perspectives in Health Magazine, The Magazine of the Pan American Health Organization, Special Centennial Edition 7 (1), 2002.

Peters CJ. Into the Future. In: Lashley FR, Durham, J.D., ed. Emerging Infectious Diseases, Trends and Issues. New York: Springer Publishing Company, Inc., pp. 371-385, 2002.

Peters CJ, Spertzel, R., Patrick, W.C. Aerosol technology and biological weapons. In: Knobler SL, Mahmoud, A.A.F., Pray, L.A., ed. Biological Threats and Terrorism, Assessing the Science and Response Capabilities. Workshop Summary of the Forum on Emerging Infections, Board on Global Health, Institute of Medicine. Washington, DC: National Academy Press, pp. 66-76, 2002.

Peters CJ. The role of antivirals in responding to biological threats. In: Knobler SL, Mahmoud, A.A.F., Pray, L.A., ed. Biological Threats and Terrorism, Assessing the Science and Response Capabilities. Workshop Summary of the Forum on Emerging Infections, Board on Global Health, Institute of Medicine. Washington, DC: National Academy Press, pp. 119-130, 2002.

Peters CJ. Arenaviruses. In: Richman DD, Whitley, R.J., Hayden, F.G., ed. Clinical Virology. Second ed. Washington, DC: ASM Press, pp. 949-969, 2002.

Pittman PR, McClain, D., Coonan, K., Makuch, R.S., Gibbs, P., Morrill, J.C., Peters, C.J. Safety and Immunogenicity of a Live-Attenuated, Mutagenized Rift Valley Fever Vaccine in Humans. The Lancet, 2002.

Poast J, Seidel HM, Hendricks MD, Haslam JA, Levy HB, Baron S. Poly I:CLC induction of the interferon system in mice: an initial study of four detection methods. J Interferon Cytokine Res 22 (10): 1035-40, 2002.

Pyles RB, Higgins D, Chalk C, Zalar A, Eiden J, Brown C, Van Nest G, Stanberry LR. Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection. J Virol 76 (22): 11387-96, 2002.

Rady PL, Szucs S, Grady J, Hudnall SD, Kellner LH, Nitowsky H, Tyring SK, Matalon RK. Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas; a report of a novel MTHFR polymorphic site, G1793A. Am J Med Genet 107 (2): 162-8, 2002.

Rady PL, Surendran S, Vu AT, Hawkins JC, Michals-Matalon K, Tyring SK, Merren J, Kumar AK, Matalon R. Founder Mutation R245H of Sanfilippo Syndrome Type A in the Cayman Islands. Genet Test 6 (3): 211-5, 2002.

Ribardo DA, Kuhl KR, Peterson JW, Chopra AK. Role of melittin-like region within phospholipase A(2)-activating protein in biological function. Toxicon 40 (5): 519-26, 2002.

Ribardo DA, Kuhl KR, Boldogh I, Peterson JW, Houston CW, Chopra AK. Early cell signaling by the cytotoxic enterotoxin of Aeromonas hydrophila in macrophages. Microb Pathog 32 (4): 149-63, 2002.

Ribardo DA, Peterson JW, Chopra AK. Phospholipase A2-activating protein--an important regulatory molecule in modulating cyclooxygenase-2 and tumor necrosis factor production during inflammation. Indian J Exp Biol 40 (2): 129-38, 2002.

Rockley P, Tyring, S.K. Herpes virus B. In: Tyring SK, ed. Mucocutaneous Manifestations of Viral Diseases. New York: Marcel Dekker, Inc., pp. 235-245, 2002.

Rosenthal SL, Griffith JO, Succop PA, Biro FM, Lewis LM, DeVellis RF, Stanberry LR. The relationship between STD locus of control and STD acquisition among adolescent girls. Adolescence 37 (145): 83-92, 2002.

Rosenthal SL, Cotton S, Ready JN, Potter LS, Succop PA. Adolescents' Attitudes and Experiences Regarding Levonorgestrel 100 mcg/Ethinyl Estradiol 20 mcg. J Pediatr Adolesc Gynecol 15 (5): 301-5, 2002.

Sahu GK, Tai PC, Chatterjee SB, Lin MH, Tennant B, Gerin J, Shih C. Out-of-frame versus in-frame core internal deletion variants of human and woodchuck hepatitis B viruses. Virology 292 (1): 35-43, 2002.

Saini SS, Gessell-Lee, D.L., Peterson, J.W. Novel inhibitors of Bacillus anthracis edema factor. Science, 2002.

Saini SS, Gessell-Lee, D.L., Peterson, J.W. COX-2-specific inhibitor celecoxib inhibits adenylyl cyclase. Inflammation, 2002.

Salazar-Bravo J, Dragoo, J.W., Bowen, M.D., Peters, C.J., Ksiazek, T.G., Yates, T.L. Natural nidality in Bolivian hemorrhagic fever and the systematics of the reservoir species. Infection, Genetics and Evolution 1: 191-199, 2002.

Schein CH, Ozgun N, Izumi T, Braun W. Total sequence decomposition distinguishes functional modules, "molegos" in apurinic/apyrimidinic endonucleases. BMC Bioinformatics 3 (1): 37, 2002.

Sha J, Kozlova EV, Chopra AK. Role of various enterotoxins in Aeromonas hydrophila-induced gastroenteritis: generation of enterotoxin gene-deficient mutants and evaluation of their enterotoxic activity. Infect Immun 70 (4): 1924-35, 2002.

Simmons A. Clinical manifestations and treatment considerations of herpes simplex virus infection. J Infect Dis 186 Suppl 1: S71-7, 2002.

Stanberry LR, Rosenthal SL. Genital herpes simplex virus infection in the adolescent: special considerations for management. Paediatr Drugs 4 (5): 291-7, 2002.

Stanberry LR, Spruance SL, Cunningham AL, Bernstein DI, Mindel A, Sacks S, Tyring S, Aoki FY, Slaoui M, Denis M, Vandepapeliere P, Dubin G. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 347 (21): 1652-61, 2002.

Stanberry LR. Herpes Simplex Virus Infections: Behavioural and Biomedical Aspects [Invited Editorial]. HERPES 9: 59, 2002.

Stetson CL, Rapini RP, Tyring SK, Kimbrough RC. CD4+ T lymphocytopenia with disseminated HPV. J Cutan Pathol 29 (8): 502-5, 2002.

Strikas RA, Wallace GS, Myers MG. Influenza pandemic preparedness action plan for the United States: 2002 update. Clin Infect Dis 35 (5): 590-6, 2002.

Suk FM, Lin MH, Newman M, Pan S, Chen SH, Liu JD, Shih C. Replication advantage and host factor-independent phenotypes attributable to a common naturally occurring capsid mutation (I97L) in human hepatitis B virus. J Virol 76 (23): 12069-77, 2002.

Sun J, Van Houten N. CD40 stimulation in vivo does not inhibit CD4+ T cell tolerance to soluble antigens. Immunol Lett 84 (2): 125, 2002.

Surendran S, Michals-Matalon K, Krywawych S, Qazi QH, Tuchman R, Rady PL, Tyring SK, Matalon R. DOOR syndrome: Deficiency of E1 component of the 2-oxoglutarate dehydrogenase complex. Am J Med Genet 113 (4): 371-4, 2002.

Tabet S, Sanchez J, Lama J, Goicochea P, Campos P, Rouillon M, Cairo JL, Ueda L, Watts D, Celum C, Holmes KK. HIV, syphilis and heterosexual bridging among Peruvian men who have sex with men. Aids 16 (9): 1271-7, 2002.

Tai PC, Suk FM, Gerlich WH, Neurath AR, Shih C. Hypermodification and immune escape of an internally deleted middle-envelope (M) protein of frequent and predominant hepatitis B virus variants. Virology 292 (1): 44-58, 2002.

Talpada M, Rauf SJ, Walling DM. Primary Nocardia osteomyelitis as a presentation of AIDS. AIDS Read 12 (2): 75-8, 2002.

Tesh RB, Travassos da Rosa AP, Guzman H, Araujo TP, Xiao SY. Immunization with heterologous flaviviruses protective against fatal West Nile encephalitis. Emerg Infect Dis 8 (3): 245-51, 2002.

Tesh RB. Viral hemorrhagic fevers of South America. Biomedica (Bogota) 22 (3): 287-95, 2002.

Tesh RB, Arroyo J, Travassos Da Rosa AP, Guzman H, Xiao SY, Monath TP. Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model. Emerg Infect Dis 8 (12): 1392-7, 2002.

Thiviyanathan V, Vyazovkina KV, Gozansky EK, Bichenchova E, Abramova TV, Luxon BA, Lebedev AV, Gorenstein DG. Structure of hybrid backbone methylphosphonate DNA heteroduplexes: effect of R and S stereochemistry. Biochemistry 41 (3): 827-38, 2002.

Tian B, Zhang Y, Luxon BA, Garofalo RP, Casola A, Sinha M, Brasier AR. Identification of NF-kappaB-dependent gene networks in respiratory syncytial virus-infected cells. J Virol 76 (13): 6800-14, 2002.

Travassos da Rosa AP, Mather TN, Takeda T, Whitehouse CA, Shope RE, Popov VL, Guzman H, Coffey L, Araujo TP, Tesh RB. Two new rhabdoviruses (Rhabdoviridae) isolated from birds during surveillance for arboviral encephalitis, northeastern United States. Emerg Infect Dis 8 (6): 614-8, 2002.

Tsai TF, Monath, T.P., WEAVER, S.C. Alphaviruses. In: Richman DD, Whitley, R.J., Hayden, F.G., ed. Clinical Virology: Churchill Livingstone, pp. 1177-1210, 2002.

Tseng CT, Klimpel GR. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J Exp Med 195 (1): 43-9, 2002.

Tyring SK, Baker D, Snowden W. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir. J Infect Dis 186 Suppl 1: S40-6, 2002.

Tyring SK. Introduction to viral diseases. In: Tyring SK, ed. Mucocutaneous Manifestations of Viral Diseases. New York: Marcel Dekker,Inc., pp. 1-24, 2002.

Valbuena G, Feng HM, Walker DH. Mechanisms of immunity against rickettsiae. New perspectives and opportunities offered by unusual intracellular parasites. Microbes Infect 4 (6): 625-33, 2002.

Van Rensburg HG, Mason PW. Construction and evaluation of a recombinant foot-and-mouth disease virus: implications for inactivated vaccine production. Ann N Y Acad Sci 969: 83-7, 2002.

Vander Straten M, Tyring SK. Mucocutaneous manifestations of viral diseases in children. Clin Dermatol 20 (1): 67-73, 2002.

Vander Straten MR, Tyring SK. Rubella. Dermatol Clin 20 (2): 225-31, 2002.

Vander Straten M, Carrasco, D., Tyring, S.K. Viral infection involving the skin. In: Richman DD, Whitley, R.J., Hayden, F.G., ed. Clinical Virology. Washington, D.C.: ASM Press, pp. 117-134, 2002.

Vanlandingham DL, Davis BS, Lvov DK, Samokhvalov E, Lvov SD, Black WC, Higgs S, Beaty BJ. Molecular characterization of California serogroup viruses isolated in Russia. Am J Trop Med Hyg 67 (3): 306-9, 2002.

Vinetz JM, Gilman RH. Asymptomatic Plasmodium parasitemia and the ecology of malaria transmission. Am J Trop Med Hyg 66 (6): 639-40, 2002.

Volk DE, Power, T. D., Gorenstein, D. G., Luxon, B. A. An ab initio study of phosphorothioate and phosphorodithioate interactions with sodium cation. Tet. Lett. 43: 4443-4447, 2002.

Volk DE, Power, T.D., Gorenstein, D.G., Luxon, B.A. An ab initio Study of Phosphorothioate Binding Interactions with Sodium Cation. Tetrahedron Letters 43: 4443-4447, 2002.

Walker DH. Electronic protocol review system--reply from the authors. Contemp Top Lab Anim Sci 41 (2): 7, 2002.

Walker DH. Rickettsia rickettsii: as virulent as ever. Am J Trop Med Hyg 66 (5): 448-9, 2002.

Walker DH, Yu, X.J. Rickettsia, Orientia, Ehrlichia and Coxiella. In: Greenwood D, Slack, R.C., Peutherer, J.F., ed. Medical Microbiology. London, UK: Elsevier Science Ltd, pp. 369-378, 2002.

Walling DM, Hudnall, S.D., Yen-Moore, A. Epstein-Barr virus. In: Tyring SK, ed. Mucocutaneous Manifestations of Viral Diseases. New York: Marcel Decker, Inc., pp. 145-171, 2002.

Weller SC, Baer RD, de Alba Garcia JG, Glazer M, Trotter R, Pachter L, Klein RE. Regional variation in Latino descriptions of susto. Cult Med Psychiatry 26 (4): 449-72, 2002.

Weller SC, Baer, R.D. Measuring within and between group agreement: Identifying the proportion of shared and unique beliefs across samples. Field Methods 14 (1): 6-25, 2002.

Welliver RC, Garofalo RP, Ogra PL. Beta-chemokines, but neither T helper type 1 nor T helper type 2 cytokines, correlate with severity of illness during respiratory syncytial virus infection. Pediatr Infect Dis J 21 (5): 457-61, 2002.

Wimberly YH, Cotton S, Wanchick AM, Succop PA, Rosenthal SL. Attitudes and experiences with levonorgestrel 100 microg/ethinyl estradiol 20 microg among women during a 3-month trial. Contraception 65 (6): 403-6, 2002.

Woods CW, Karpati AM, Grein T, McCarthy N, Gaturuku P, Muchiri E, Dunster L, Henderson A, Khan AS, Swanepoel R, Bonmarin I, Martin L, Mann P, Smoak BL, Ryan M, Ksiazek TG, Arthur RR, Ndikuyeze A, Agata NN, Peters CJ. An outbreak of Rift Valley fever in Northeastern Kenya, 1997-98. Emerg Infect Dis 8 (2): 138-44, 2002.

Yang X, Bassett SE, Li X, Luxon BA, Herzog NK, Shope RE, Aronson J, Prow TW, Leary JF, Kirby R, Ellington AD, Gorenstein DG. Construction and selection of bead-bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries designed for rapid PCR-based sequencing. Nucleic Acids Res 30 (23): e132, 2002.

Yang Y, Rijnbrand R, McKnight KL, Wimmer E, Paul A, Martin A, Lemon SM. Sequence requirements for viral RNA replication and VPg uridylylation directed by the internal cis-acting replication element (cre) of human rhinovirus type 14. J Virol 76 (15): 7485-94, 2002.

Yang X, Hodge RP, Luxon BA, Shope R, Gorenstein DG. Separation of synthetic oligonucleotide dithioates from monothiophosphate impurities by anion-exchange chromatography on a mono-q column. Anal Biochem 306 (1): 92-9, 2002.

Yeung-Yue KA, Brentjens MH, Lee PC, Tyring SK. Herpes simplex viruses 1 and 2. Dermatol Clin 20 (2): 249-66, 2002.

Yeung-Yue KA, Brentjens MH, Lee PC, Tyring SK. The management of herpes simplex virus infections. Curr Opin Infect Dis 15 (2): 115-22, 2002.

Yi M, Bodola F, Lemon SM. Subgenomic hepatitis C virus replicons inducing expression of a secreted enzymatic reporter protein. Virology 304 (2): 197-210, 2002.

Yi M, Lemon SM. Replication of subgenomic hepatitis A virus RNAs expressing firefly luciferase is enhanced by mutations associated with adaptation of virus to growth in cultured cells. J Virol 76 (3): 1171-80, 2002.

Young SL, Lessey BA, Fritz MA, Meyer WR, Murray MJ, Speckman PL, Nowicki BJ. In vivo and in vitro evidence suggest that HB-EGF regulates endometrial expression of human decay-accelerating factor. J Clin Endocrinol Metab 87 (3): 1368-75, 2002.

Yu XJ, Walker, D.H. The Order Rickettsiales. In: Dworkin M, Falkow, S., Rosenberg, E., Schleifer, K.H., Stackebrandt, E., ed. The Prokaryotes: An evolving electronic resource for the microbiological community. New York: Springer-Verlag, 2002.

Zhang S, Gorenstein DG. Coherent excitation with phase-incremented pulses. J Magn Reson 154 (1): 73-9, 2002.

Zhang S, Gorenstein, D.G. Suppression of Linearly Responsive Residual Water. Concepts in Magn. Reson 14: 102-111, 2002.

Zong J, Ciufo DM, Viscidi R, Alagiozoglou L, Tyring S, Rady P, Orenstein J, Boto W, Kalumbuja H, Romano N, Melbye M, Kang GH, Boshoff C, Hayward GS. Genotypic analysis at multiple loci across Kaposi's sarcoma herpesvirus (KSHV) DNA molecules: clustering patterns, novel variants and chimerism. J Clin Virol 23 (3): 119-48, 2002.